GB1008466A - Improvements in or relating to lysergol derivatives - Google Patents

Improvements in or relating to lysergol derivatives

Info

Publication number
GB1008466A
GB1008466A GB43625/61A GB4362561A GB1008466A GB 1008466 A GB1008466 A GB 1008466A GB 43625/61 A GB43625/61 A GB 43625/61A GB 4362561 A GB4362561 A GB 4362561A GB 1008466 A GB1008466 A GB 1008466A
Authority
GB
United Kingdom
Prior art keywords
formula
alkoxy
reacting
substituted
lysergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB43625/61A
Inventor
Albert Hofmann
Franz Troxler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Patent Ltd
Sandoz AG
Original Assignee
Sandoz Patent Ltd
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1438160A external-priority patent/CH392537A/en
Application filed by Sandoz Patent Ltd, Sandoz AG filed Critical Sandoz Patent Ltd
Publication of GB1008466A publication Critical patent/GB1008466A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention comprises 1-substituted lysergols of general formula <FORM:1008466/C2/1> in which R1 is C1- 14 alkyl, C2- 4 alkenyl or C7- 10 aralkyl and x y signifies <FORM:1008466/C2/2> or <FORM:1008466/C2/3> and the addition salts of these compounds with inorganic or organic acids; and a process for their preparation in which a compound of formula <FORM:1008466/C2/4> in which R2 is alkoxy, aralkoxy or a 3,5-dialkylpyrazolyl-(1) radical, is reduced. In the process, suitable reducing agents are lithium aluminium hydride when x y is a double bond in both the starting material and the product, and sodium in alcohol when x y is saturated in the product. The compounds of Formula II may be produced by (1) alkylating or alkenylating a corresponding ester which is unsubstituted in the 1-position (only when R2 is alkoxy or aralkoxy), (2) converting a corresponding 1-substituted lysergic or dihydrolysergic acid into its halide and esterifying with the desired alcohol, the acid being obtained by alkaline saponification of a 1-substituted ergot alkaloid (only when R2 is alkoxy or aryloxy), (3) reacting with hydrazine a 1-substituted ergot alkaloid, converting the hydrazide with nitrous acid into the azide and reacting the azide with R2OH (only when R2 is alkoxy or aryloxy), and (4) reacting the hydrazide of (3) with an a b -diketone alkyl-CO-CH2CO-alkyl (only when R2 is a 3,5-dialkylpyrazolyl-(1) radical). Detailed examples describe the preparation of compounds of both Formula I and Formula II by the above methods; the preparations of 1-allyl -D-lysergic acid methyl ester and 1-benzyl -D-lysergic acid methyl ester by reacting D-lysergic acid in liquid ammonia with sodium amide and allyl or benzyl bromide and esterifying with diazomethane are also illustrated. The lysergic acid derivatives of the invention, which are stated to exhibit a serotonin inhibiting effect and a beneficial effect on the psyche, rheumatism, allergies, inflammations and migraine, may be made up into pharmaceutical compositions with suitable carriers. Specifications 911,115, 948,203 and 988,001 are referred to.
GB43625/61A 1960-12-23 1961-12-06 Improvements in or relating to lysergol derivatives Expired GB1008466A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1438160A CH392537A (en) 1960-12-23 1960-12-23 Process for the preparation of new heterocyclic alcohols
CH1230761 1961-10-25

Publications (1)

Publication Number Publication Date
GB1008466A true GB1008466A (en) 1965-10-27

Family

ID=25710011

Family Applications (1)

Application Number Title Priority Date Filing Date
GB43625/61A Expired GB1008466A (en) 1960-12-23 1961-12-06 Improvements in or relating to lysergol derivatives

Country Status (3)

Country Link
AT (1) AT240530B (en)
FR (1) FR1860M (en)
GB (1) GB1008466A (en)

Also Published As

Publication number Publication date
AT240530B (en) 1965-06-10
FR1860M (en) 1963-06-17

Similar Documents

Publication Publication Date Title
IE36797L (en) 1,5-benzodiazepin-2-one derivatives.
GB1008466A (en) Improvements in or relating to lysergol derivatives
ES454063A1 (en) Novel benzylalcohol derivatives and processes for preparing the same
GB999589A (en)
GB1073828A (en) O-desacetyl-o-carbamoyl-7-acylamino-cephalosporanic acids
GB1139458A (en) 2-phenylamino-2-oxazolines and their production
GB1319346A (en) Heterocyclic substituted vinyl phsophates
GB1347598A (en) Lincomycin derivatives and the manufacture thereof
ES254772A1 (en) Certain nu-(3, 5-diiodo-4-pyridonealkanoyl)-aminoalkanoic acids
ES8602685A1 (en) Imidazole derivative and its preparation
GB1173372A (en) Substituted 3-Aminopyrrolidines
GB961265A (en) 3,4-dihydroxyphenyl-acetic acid ester derivatives
GB1351526A (en) Tropan-3-ol derivatives and processes for their preparation
GB1017979A (en) Improvements in or relating to the preparation of chloro-acetoacetamides and to substituted dioxolan derivatives of acetic acid esters as intermediates in said preparation
GB1088880A (en) ª‡-cycloalkyleneimino-substituted esters
GB721477A (en) 4-aminobenzoic acid ester compounds of penicillin
GB1056475A (en) Process for preparing 4-amino-pyrazolone derivatives
ES345183A1 (en) Glycyrrhetinic acid derivatives
GB1095185A (en) Phenylalanine derivatives
GB729331A (en) Improvements in or relating to thiazole derivatives
GB1138247A (en) Oleanolic acid derivatives
GB866432A (en) New carboxylic acid amides substituted at the nitrogen atom and ª--carbon atom
GB922028A (en) New therapeutically-valuable organic compounds and processes for their preparation
ES387584A1 (en) Alkyl 1 1a 2 6b-tetrahydrocycloprop(b)indole 1-carboxylates and acids
GB950509A (en) Improvements in or relating to piperazides